NMRLP - Overview: Nuclear Magnetic Resonance Lipoprotein Profile, Serum
Assessment and management of a patient's risk for atherosclerotic cardiovascular disease Identifying residual risk that may be present in some patients on cholesterol targeting treatment
OSCAL - Overview: Osteocalcin, Serum
Monitoring and assessing effectiveness of antiresorptive therapy in patients treated for osteopenia, osteoporosis, Paget disease, or other disorders in which osteocalcin levels are elevated As an adjunct in the diagnosis of medical...
ALPRT - Overview: Alport (Collagen IV Alpha 5 and Alpha 2) Immunofluorescent Stain, Renal Biopsy
Assisting in the diagnosis of hereditary nephritis (Alport syndrome)
BART - Overview: Bartonella Antibody Panel, IgG and IgM, Serum
Diagnosis of Bartonella infection, especially in the context of a cat scratch
Determining class I human leukocyte antigens (HLA) on specimens for those patients who have become refractory to platelet transfusions and identify potential disease associations or markers for drug hypersensitivity
FENTU - Overview: Fentanyl with Metabolite Confirmation, Random, Urine
Detection and confirmation of illicit drug use involving fentanyl
GATOL - Overview: Galactitol, Quantitative, Urine
Monitoring effectiveness of treatment in patients with galactosemia Establishing a baseline level prior to initiating treatment for galactosemia
BUPM - Overview: Buprenorphine and Norbuprenorphine, Random, Urine
Monitoring of compliance utilizing buprenorphine Detection and confirmation of the illicit use of buprenorphine
DIPGS - Overview: Diphtheria Toxoid IgG Antibody, Serum
Determining a patient's immunological response to diphtheria toxoid vaccination Aiding in the evaluation of immunodeficiency
FFT4F - Overview: T4, Free, Direct Dialysis
T4, Free, Direct Dialysis
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....